InvestorsHub Logo

s1t0ru5

03/22/19 1:06 PM

#25896 RE: s1t0ru5 #25895

$KALY - In summary, no patients in the first cohort of the Phase 2 clinical study have developed grades 3 or 4 acute GVHD while receiving oral CBD treatment, and only one patient developed grade 2 acute GVHD. ...

#BottomFishing #cbdStocks

BAD HEMPER

03/22/19 1:07 PM

#25897 RE: s1t0ru5 #25895

WOW. Where did you find this. LOVE IT

killak

03/22/19 1:16 PM

#25898 RE: s1t0ru5 #25895

Kalytera is a different company..